FindTrial
Sign In

A study of Chewable Gummies for Fine Line/Wrinkles, Hyperpigmentary Spots and Under Eyes Dark Circles.

An Open Label, Single-Arm, Clinical Study to Evaluate Efficacy and Safety of Chewable Gummies in Healthy Adult Subjects with Fine Line/Wrinkles, Hyperpigmentary Spots and Under Eyes Dark Circles.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/045104
Enrollment
36
Registered
2022-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nyumi Radiant Skin Gummies: Simply chew and swallow 2 gummies together after dinner for 75 days. Control Intervention1: NA: NA

Sponsors

Ikaria Wellness Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subject has a fine line/wrinkles score of â??2â?? (Few number of discreet fine lines) or greater surrounding the crowâ??s feet area as per Physician Global Assessment (PGA). 2.Subject has at least 2 hyperpigmentary spots on the face. 3.Subjects with Grade 2 and Grade 3 under eyes dark circles as determined by 6-point grading scale.

Exclusion criteria

Exclusion criteria: 1.Subjects having any active dermatological skin diseases (e.g., psoriasis, atopic dermatitis, rosacea etc.), that might interfere with clinical assessments. 2.Subjects with any pigmentary disorder including Freckles and melasma. 3.Subject having excessive hair, moles, open wounds, cuts, abrasions, irritation symptoms, tattoos, scars, sunburn or any dermatological condition on the test site(s) that can interfere with the reading. 4.Subjects who are receiving topical or systemic treatments.

Design outcomes

Primary

MeasureTime frame
Assessment of fine line/wrinkles, skin dryness, coarse wrinkling/lines, laxity by Physician Global Assessment (PGA) using Griffiths Scale by DermatologistTimepoint: Day 01 (before application), Day 25 (plus minus 02 Days), Day 50 (plus minus 02 Days) and Day 75 (plus minus 02 Days).—

Secondary

MeasureTime frame
Assessment of Fine wrinkling, Coarse wrinkling, laxity using Severity Scoring by DermatologistTimepoint: Day 01 (before application), Day 25 (plus minus 02 Days), Day 50 (plus minus 02 Days) and Day 75 (plus minus 02 Days);Assessment of Skin firmness using Cutometer dual MPA 580Timepoint: Day 01 (before application), Day 25 (plus minus 02 Days), Day 50 (plus minus 02 Days) and Day 75 (plus minus 02 Days).;Assessment of Skin gloss using Skin-Glossymeter GL 200Timepoint: Day 01 (before application), Day 25 (plus minus 02 Days), Day 50 (plus minus 02 Days) and Day 75 (plus minus 02 Days).;Assessment of Skin Moisturization using Corneometer® CM 825 / MoistureMeterSCTimepoint: Day 01 (before application), Day 25 (plus minus 02 Days), Day 50 (plus minus 02 Days) and Day 75 (plus minus 02 Days).;Assessment of skin pigment using 9-point scale by DermatologistTimepoint: Day 01 (before application), Day 25 (plus minus 02 Days), Day 50 (plus minus 02 Days) and Day 75 (plus minus 02 Days).;Assessment of skin pigmentation using Mexameter® MX 18Timepoint: Day 01 (before application), Day 25 (plus minus 02 Days), Day 50 (plus minus 02 Days) and Day 75 (plus minus 02 Days).;Assessment of Skin radiance using Modified Griffiths Scale by DermatologistTimepoint: Day 01 (before application), Day 25 (plus minus 02 Days), Day 50 (plus minus 02 Days) and Day 75 (plus minus 02 Days).;Assessment of under-eyes dark circles using 6-point grading scale by DermatologistTimepoint: Day 01 (before application), Day 25 (plus minus 02 Days), Day 50 (plus minus 02 Days) and Day 75 (plus minus 02 Days).;Assessment of uneven skin tone using Felix Von Luschan Skin colour chartTimepoint: Day 01 (before application), Day 25 (plus minus 02 Days), Day 50 (plus minus 02 Days) and Day 75 (plus minus 02 Days).;Assessment of wrinkles of crowâ??s feet area, pigmentation, skin texture and under-eyes dark circles using 3D analysis systemTimepoint: Day 01 (before application), Day 25 (plus minus 02 Days), Day 50 (—

Countries

India

Contacts

Public ContactDr Simran Sethi

Cliantha Research

pjoshi@cliantha.com8000085049

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026